Advancing Patient-Centered, Guideline-Driven Management of Hyperkalemia in Adults With CKD and Associated Comorbidities
James Burton, DM, FRCP
Nihar R. Desai, MD, MPH
Pauline A. Swift, PhD
Navigating KDIGO Practice Guideline Recommendations to Maximize Proteinuria Reduction in Patients With IgAN
Chee Kay Cheung, MBChB, PhD, FRCP
Claudia Seikrit, MD
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
Antoine Lanot, MD, PhD
Gil Yosipovitch, MD
Targeting CKD-aP at the Source: Key Mechanisms and Treatments
Steven Fishbane, MD
Maurizio Gallieni, MD
Individualized Management of Hyperkalemia: The Role of Potassium Binders in Patients With Cardiorenal Disease
Ellie Kelepouris, MD, FACP, FAHA
The Patient-Clinician Connection in Managing CKD-aP
Lucio Manenti, MD, PhD
Improving Sleep and Mental Health in Patients with CKD-aP
Leonie Kraft, MD
Kappa-Opioid Settings: Real-World Evidence Insights
Emilio Sanchez, MD, PhD
Elevating CKD-aP Care: New Frontier
CKD-aP or Something Else? Decoding the Diagnosis
CKD-aP: Beyond the Surface
CKD-aP Treatment Tool Kit
Quantifying CKD-aP: Tools for Better Care
Is CKD-aP Hiding in Your Dialysis Center?
Precision Medicine in IgAN: A Deep Dive into Biomarkers, Evolving Guidelines, and Therapeutic Frontiers
Raphael Duivenvoorden, MD, PhD
Achieving Success in IgAN & FSGS
Siân Griffin, MD, PhD
Jürgen Floege, MD
Loreto Gesualdo, MD, FERA
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Kidney Academy… but how about a more personalized experience?
Press cancel to remain on Global Kidney Academy. Press the link below or the continue button to keep going.